194 related articles for article (PubMed ID: 12234095)
1. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.
Lieb ME; Menzies K; Moschella MC; Ni R; Taubman MB
Biochem Cell Biol; 2002; 80(4):421-6. PubMed ID: 12234095
[TBL] [Abstract][Full Text] [Related]
2. Characterization and comparative analysis of the EGLN gene family.
Taylor MS
Gene; 2001 Sep; 275(1):125-32. PubMed ID: 11574160
[TBL] [Abstract][Full Text] [Related]
3. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.
Fu J; Menzies K; Freeman RS; Taubman MB
J Biol Chem; 2007 Apr; 282(17):12410-8. PubMed ID: 17344222
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
To KK; Huang LE
J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
[TBL] [Abstract][Full Text] [Related]
5. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen.
del Peso L; Castellanos MC; Temes E; Martin-Puig S; Cuevas Y; Olmos G; Landazuri MO
J Biol Chem; 2003 Dec; 278(49):48690-5. PubMed ID: 14506252
[TBL] [Abstract][Full Text] [Related]
6. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.
Villar D; Vara-Vega A; Landázuri MO; Del Peso L
Biochem J; 2007 Dec; 408(2):231-40. PubMed ID: 17725546
[TBL] [Abstract][Full Text] [Related]
7. Dynamic HIF1A regulation during human placental development.
Ietta F; Wu Y; Winter J; Xu J; Wang J; Post M; Caniggia I
Biol Reprod; 2006 Jul; 75(1):112-21. PubMed ID: 16611863
[TBL] [Abstract][Full Text] [Related]
8. SM-20, EGL-9, and the EGLN family of hypoxia-inducible factor prolyl hydroxylases.
Freeman RS; Hasbani DM; Lipscomb EA; Straub JA; Xie L
Mol Cells; 2003 Aug; 16(1):1-12. PubMed ID: 14503838
[TBL] [Abstract][Full Text] [Related]
9. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.
Strocchi S; Reggiani F; Gobbi G; Ciarrocchi A; Sancisi V
Oncogene; 2022 Jul; 41(29):3665-3679. PubMed ID: 35705735
[TBL] [Abstract][Full Text] [Related]
10. Proline hydroxylation and gene expression.
Kaelin WG
Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.
Fu J; Taubman MB
J Biol Chem; 2010 Mar; 285(12):8927-35. PubMed ID: 20089853
[TBL] [Abstract][Full Text] [Related]
12. The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.
Hatzimichael E; Dasoula A; Shah R; Syed N; Papoudou-Bai A; Coley HM; Dranitsaris G; Bourantas KL; Stebbing J; Crook T
Eur J Haematol; 2010 Jan; 84(1):47-51. PubMed ID: 19737309
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the role of the HIF hydroxylase family members in erythropoiesis.
Fisher TS; Lira PD; Stock JL; Perregaux DG; Brissette WH; Ozolins TR; Li B
Biochem Biophys Res Commun; 2009 Oct; 388(4):683-8. PubMed ID: 19683512
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
Astuti D; Ricketts CJ; Chowdhury R; McDonough MA; Gentle D; Kirby G; Schlisio S; Kenchappa RS; Carter BD; Kaelin WG; Ratcliffe PJ; Schofield CJ; Latif F; Maher ER
Endocr Relat Cancer; 2011 Feb; 18(1):73-83. PubMed ID: 20959442
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
16. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.
Lee S; Nakamura E; Yang H; Wei W; Linggi MS; Sajan MP; Farese RV; Freeman RS; Carter BD; Kaelin WG; Schlisio S
Cancer Cell; 2005 Aug; 8(2):155-67. PubMed ID: 16098468
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
18. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene.
Pescador N; Cuevas Y; Naranjo S; Alcaide M; Villar D; Landázuri MO; Del Peso L
Biochem J; 2005 Aug; 390(Pt 1):189-97. PubMed ID: 15823097
[TBL] [Abstract][Full Text] [Related]
19. Suppression of glioma progression by Egln3.
Sciorra VA; Sanchez MA; Kunibe A; Wurmser AE
PLoS One; 2012; 7(8):e40053. PubMed ID: 22905089
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HIF-prolyl hydroxylases binding to substrates.
Landázuri MO; Vara-Vega A; Vitón M; Cuevas Y; del Peso L
Biochem Biophys Res Commun; 2006 Dec; 351(2):313-20. PubMed ID: 17069766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
